Clinical Review Evidence based cardiology

Prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction

BMJ 1999; 318 doi: http://dx.doi.org/10.1136/bmj.318.7195.1400 (Published 22 May 1999) Cite this as: BMJ 1999;318:1400
  1. R S McKelvie ([email protected]), career scientist, Ontario Ministry of Healtha,
  2. C R Benedict, director of heart failure programmeb,
  3. S Yusuf, career investigator, Medical Research Council of Canadaa
  1. a Department of Medicine, Division of Cardiology, McMaster University, Hamilton Health Sciences Corporation-General Division, 237 Barton Street East, Hamilton, ON, Canada L8L 2X2
  2. b Division of Cardiology, University of Texas, Health Sciences Centre, 6431 Fannin, Houston, TX 77030, USA
  1. Correspondence to: Dr R S McKelvie

    This is the second of four articles

    The epidemiology of heart failure has been studied largely among symptomatic individuals because identification of these patients is based on clinical criteria and does not require measuring left ventricular function.1 However, identifying people who are at high risk of heart failure could lead to the implementation of strategies that could potentially prevent heart failure and improve prognosis. This article reviews the prevalence of left ventricular dysfunction, the management of asymptomatic left ventricular dysfunction, and the prevention of heart failure.

    Summary points

    • Asymptomatic left ventricular dysfunction seems to be common

    • Risk factors for the development of heart failure exist and may be used to determine those patients at greatest risk of left ventricular dysfunction

    • Aggressive control of these risk factors is important

    • Although screening of people at high risk may be of value, at this time it cannot be justified

    Prevalence of left ventricular dysfunction

    The data on the prevalence of asymptomatic left ventricular dysfunction are limited, even though treatment of patients with this condition may be expected to improve their outcome.23 In 1992 McDonagh et al measured ejection fraction in 1467 people during a survey of coronary risk factors.3 The mean ejection fraction was 47% among people defined as not having cardiovascular disease, and 34% was two standard deviations below the mean. Of the 2.9% with an ejection fraction of 30%, half had no symptoms. The frequency of both left ventricular dysfunction and symptoms was greater in older age groups, increasing sharply up to the age of 45 and less sharply thereafter (table 1). Of the 7.7% with an ejection fraction of 35%, 77% were asymptomatic. Of those with definite left ventricular dysfunction (table 1), the proportion with symptoms increased with age. The group with left ventricular dysfunction had a greater prevalence of ischaemic heart …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe